Faculty of Medicine;
J.J.Strossmayer University Osijek;
Osijek 31000;
Croatia;
Department for Endocrinology;
Diabetes and Clinical Pharmacology;
Clinical Hospital Dubrava;
Zagreb 10000;
Croatia;
Department of Kinesiological Anthropology and Methodology;
Faculty of Kinesiology;
University of Zagreb;
Zagreb 10000;
Croatia;
Department of Endocrinology and Metabolism Disorders;
Clinical Hospital Center;
Osijek 31000;
Croatia;
University Clinic for Diabetes“Vuk Vrhovac”;
Merkur University Hospital;
Zagreb 10000;
Croatia;
School of Medicine;
University of Zagreb;
Zagreb 10000;
Croatia;
Department for Endocrinology;
Diabetes and Metabolism;
University Hospital Centre“Sestre milosrdnice”;
Zagreb 10000;
Croatia;
Department for Endocrinology;
Diabetes and Metabolism;
University Hospital Centre Rijeka;
School of Medicine;
University of Rijeka;
51000 Rijeka;
Croatia;
Department of Medicine;
Merkur University Hospital;
School of Medicine;
University of Zagreb;
Zagreb 10000;
Croatia;
Sodium/glucose cotransporter-2 inhibitors; Glucagon-like-1 receptor agonists; Type 2 diabetes mellitus; Body weight; Glycemic control; Cardiovascular complications;